Survey finds tariffs, tax cuts and immigration policy could weigh on price outlook for next two years.
In sports, entertainment and marketing, displays of conservatism are crowding out progressive postures.
With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.
Jimmy Vielkind is a former reporter for The Wall Street Journal, where he covered New York, New Jersey and Connecticut. His stories often looked at the impact of state policies on the tristate ...
Our hopes, fears and expectations for the first nonconsecutive White House term in 132 years.